495 related articles for article (PubMed ID: 26961869)
1. Transforming Growth Factor-β Family Ligands Can Function as Antagonists by Competing for Type II Receptor Binding.
Aykul S; Martinez-Hackert E
J Biol Chem; 2016 May; 291(20):10792-804. PubMed ID: 26961869
[TBL] [Abstract][Full Text] [Related]
2. Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophy.
Morvan F; Rondeau JM; Zou C; Minetti G; Scheufler C; Scharenberg M; Jacobi C; Brebbia P; Ritter V; Toussaint G; Koelbing C; Leber X; Schilb A; Witte F; Lehmann S; Koch E; Geisse S; Glass DJ; Lach-Trifilieff E
Proc Natl Acad Sci U S A; 2017 Nov; 114(47):12448-12453. PubMed ID: 29109273
[TBL] [Abstract][Full Text] [Related]
3. Insight into Molecular Mechanism for Activin A-Induced Bone Morphogenetic Protein Signaling.
Xie C; Jiang W; Lacroix JJ; Luo Y; Hao J
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899497
[TBL] [Abstract][Full Text] [Related]
4. Repulsive guidance molecule RGMa alters utilization of bone morphogenetic protein (BMP) type II receptors by BMP2 and BMP4.
Xia Y; Yu PB; Sidis Y; Beppu H; Bloch KD; Schneyer AL; Lin HY
J Biol Chem; 2007 Jun; 282(25):18129-18140. PubMed ID: 17472960
[TBL] [Abstract][Full Text] [Related]
5. Bone morphogenetic proteins.
Chen D; Zhao M; Mundy GR
Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
[TBL] [Abstract][Full Text] [Related]
6. Bone morphogenetic protein (BMP) type II receptor deletion reveals BMP ligand-specific gain of signaling in pulmonary artery smooth muscle cells.
Yu PB; Beppu H; Kawai N; Li E; Bloch KD
J Biol Chem; 2005 Jul; 280(26):24443-50. PubMed ID: 15883158
[TBL] [Abstract][Full Text] [Related]
7. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ
Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852
[TBL] [Abstract][Full Text] [Related]
8. Differential effect of activin A and BMP-7 on myofibroblast differentiation and the role of the Smad signaling pathway.
You L; Kruse FE
Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):72-81. PubMed ID: 11773015
[TBL] [Abstract][Full Text] [Related]
9. Competition between type I activin and BMP receptors for binding to ACVR2A regulates signaling to distinct Smad pathways.
Szilágyi SS; Amsalem-Zafran AR; Shapira KE; Ehrlich M; Henis YI
BMC Biol; 2022 Feb; 20(1):50. PubMed ID: 35177083
[TBL] [Abstract][Full Text] [Related]
10. A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptor.
Weber D; Kotzsch A; Nickel J; Harth S; Seher A; Mueller U; Sebald W; Mueller TD
BMC Struct Biol; 2007 Feb; 7():6. PubMed ID: 17295905
[TBL] [Abstract][Full Text] [Related]
11. Bone morphogenetic protein (BMP) ligands and receptors in bovine ovarian follicle cells: actions of BMP-4, -6 and -7 on granulosa cells and differential modulation of Smad-1 phosphorylation by follistatin.
Glister C; Kemp CF; Knight PG
Reproduction; 2004 Feb; 127(2):239-54. PubMed ID: 15056790
[TBL] [Abstract][Full Text] [Related]
12. Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily.
Barbara NP; Wrana JL; Letarte M
J Biol Chem; 1999 Jan; 274(2):584-94. PubMed ID: 9872992
[TBL] [Abstract][Full Text] [Related]
13. Activins bind and signal via bone morphogenetic protein receptor type II (BMPR2) in immortalized gonadotrope-like cells.
Rejon CA; Hancock MA; Li YN; Thompson TB; Hébert TE; Bernard DJ
Cell Signal; 2013 Dec; 25(12):2717-26. PubMed ID: 24018044
[TBL] [Abstract][Full Text] [Related]
14. An activin mutant with disrupted ALK4 binding blocks signaling via type II receptors.
Harrison CA; Gray PC; Fischer WH; Donaldson C; Choe S; Vale W
J Biol Chem; 2004 Jul; 279(27):28036-44. PubMed ID: 15123686
[TBL] [Abstract][Full Text] [Related]
15. Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B.
Olsen OE; Wader KF; Hella H; Mylin AK; Turesson I; Nesthus I; Waage A; Sundan A; Holien T
Cell Commun Signal; 2015 Jun; 13():27. PubMed ID: 26047946
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of BMP-9 and functional interactions with pro-region and receptors.
Brown MA; Zhao Q; Baker KA; Naik C; Chen C; Pukac L; Singh M; Tsareva T; Parice Y; Mahoney A; Roschke V; Sanyal I; Choe S
J Biol Chem; 2005 Jul; 280(26):25111-8. PubMed ID: 15851468
[TBL] [Abstract][Full Text] [Related]
17. Evidence for an inhibitory role of bone morphogenetic protein(s) in the follicular-luteal transition in cattle.
Kayani AR; Glister C; Knight PG
Reproduction; 2009 Jan; 137(1):67-78. PubMed ID: 18936084
[TBL] [Abstract][Full Text] [Related]
18. Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin.
Xia Y; Babitt JL; Sidis Y; Chung RT; Lin HY
Blood; 2008 May; 111(10):5195-204. PubMed ID: 18326817
[TBL] [Abstract][Full Text] [Related]
19. Proteomic identification and functional validation of activins and bone morphogenetic protein 11 as candidate novel muscle mass regulators.
Souza TA; Chen X; Guo Y; Sava P; Zhang J; Hill JJ; Yaworsky PJ; Qiu Y
Mol Endocrinol; 2008 Dec; 22(12):2689-702. PubMed ID: 18927237
[TBL] [Abstract][Full Text] [Related]
20. Expression of transforming growth factor-beta1, activin A, and their receptors in thyroid follicle cells: negative regulation of thyrocyte growth and function.
Franzén A; Piek E; Westermark B; ten Dijke P; Heldin NE
Endocrinology; 1999 Sep; 140(9):4300-10. PubMed ID: 10465304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
